CCR2 and neoplasm: Interestingly, both CXCR3+ and CCR2+ infiltrating CD11b+ myeloid cells were significantly enhanced within KC1-p53KO tumors (Figures 2L, 2M, and S2G), correlating with increased production of the cytokines for these receptors by the p53-deleted tumor cells.